Its safety and effectiveness for human use have not been confirmed through comprehensive clinical trials
This may sound counter intuitive to conventional use of skincare where skincare products are applied to clean and washed skin
Oral semaglutide (currently available as Rybelsus for type 2 diabetes) and newer compounds like orforglipron are in advanced clinical trials for weight management
Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, Boehringer Ingelheim, Amgen Inc., Pfizer Inc., Device Platform Developers and Design Houses, Ypsomed AG (UnoPen, YpsoMate, ServoPen, SmartPilot), SHL Medical, Owen Mumford (Aidaptus, Autoject) and Others